HCA Healthcare stock costs EUR 403.25 with a P/ E of 15.2

Published on 10/12/2026 at 15:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HCA Healthcare stock stands at EUR 403.25 on October 12, 2026 at a P/E of 15.2. Third-quarter results are scheduled for October 27, 2026.

Key points in brief

HCA Healthcare stock stood at EUR 403.25 at Lang & Schwarz on October 12, 2026, at 3:40 p.m. CEST.
The primary-market quote was USD 453.78 on the NYSE at 9:51 a.m. ET.
HCA Healthcare had a market capitalization of USD 98.2 billion and a P/E of 15.2.
Third-quarter 2026 results are scheduled for October 27, 2026.

Extreme Makroaufnahme des Stethoskop-Membranstücks aus gebürstetem Chromstahl in klinischem Licht — HCA Healthcare US40412C1018 extreme Makro Detailaufnahme eines Stethoskop Brustteils aus hochglanz poliertem Stahl, Illustration mit AI erstellt.

HCA Healthcare (ISIN US40412C1018) was trading at EUR 403.25 at Lang & Schwarz on October 12, 2026, at 3:40 p.m. CEST. Its trailing price-to-earnings ratio was 15.2, putting the valuation figure at the center of this market report.

NYSE quote and yearly range

On the NYSE, HCA Healthcare was last quoted at USD 453.78 on October 12, 2026, at 9:51 a.m. ET during the open session. Trading volume stood at 49,580 shares, compared with an average volume of 1,457,134 shares.

The 52-week range extended from USD 353.99 to USD 556.52. The primary-market quote therefore remained USD 102.74 below the yearly high and USD 99.79 above the yearly low, with both reference values in US dollars.

Valuation and scheduled results

HCA Healthcare's market capitalization was USD 98.2 billion as of October 12, 2026. The dividend yield was 0.01 percent, while the P/E ratio was 15.2 on the same market-data snapshot.

HCA Healthcare announced on September 30, 2026, that its third-quarter 2026 earnings call is scheduled for October 27, 2026, at 10:00 a.m. ET. The date gives the market a defined calendar point for the next company-specific update.

Comparison with peers

HCA Healthcare: , P/E 15.2, market capitalization USD 98.2 billion
Tenet Healthcare (NYSE, USD): plus 0.36 percent, P/E 10.2, market capitalization USD 21.3 billion
Universal Health Services (NYSE, USD): plus 0.89 percent, P/E 7.3, market capitalization USD 10.8 billion

Price remains the key reference

HCA Healthcare combines a USD 98.2 billion market capitalization with a 15.2 P/E ratio and a 0.01 percent dividend yield. The EUR 403.25 Lang & Schwarz quote provides the euro-denominated market view for investors in Germany on October 12, 2026 at 3:40 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.